Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status
- PMID: 33742744
- PMCID: PMC8504916
- DOI: 10.1111/jdi.13548
Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status
Abstract
Introduction: Fatty liver disease (FLD) is a surrogate condition for glucose intolerance development. FLD may involve normal or abnormal liver enzyme levels. Whether FLD is a risk factor for glucose intolerance, regardless of liver enzyme levels, remains unknown. We assessed relationships between the development of impaired fasting glucose (IFG) and FLD, liver enzyme abnormalities, and alcohol consumption.
Materials and methods: We retrospectively evaluated 8,664 participants with more than two annual health check-ups. Participants were classified according to sex, alcohol consumption, alanine aminotransferase (ALT) levels, and fatty liver status.
Results: In univariate analyses, IFG onset among men was related to normal or high ALT levels with FLD in the nonalcoholic and alcoholic groups (P-trend < 0.01). In multivariate analyses, IFG onset among nonalcoholic men was associated with normal or high ALT levels with FLD, independent of potential confounding factors (P-trend < 0.01). However, IFG onset was non-independently associated with any condition among alcoholic men. In univariate analyses, IFG onset among women was related to normal or high ALT levels with FLD in the nonalcoholic group (P-trend < 0.01) and high ALT levels with FLD in the alcoholic group (P-trend < 0.05). In multivariate analyses, IFG onset was independently associated with only normal ALT levels in nonalcoholic FLD women.
Conclusions: Among nonalcoholic men and women, FLD was a risk factor for IFG onset, including normal ALT concentrations. Care is needed for individuals with nonalcoholic FLD, regardless of liver injury, possibly helping reduce glucose intolerance risk.
Keywords: Abnormal glucose tolerance; Fatty liver; Normal alanine aminotransferase.
© 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The author declares no conflict of interest.
Figures
Similar articles
-
Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.J Gastroenterol. 2016 Nov;51(11):1090-1100. doi: 10.1007/s00535-016-1194-0. Epub 2016 Mar 12. J Gastroenterol. 2016. PMID: 26971094
-
Prevalence and associated metabolic factors of fatty liver disease in the elderly.Exp Gerontol. 2013 Aug;48(8):705-9. doi: 10.1016/j.exger.2013.05.059. Epub 2013 May 27. Exp Gerontol. 2013. PMID: 23721951
-
Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China.Endocr Pract. 2018 Sep;24(9):823-832. doi: 10.4158/EP-2018-0098. Epub 2018 Jul 5. Endocr Pract. 2018. PMID: 29975579
-
Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.Phytother Res. 2019 Mar;33(3):561-570. doi: 10.1002/ptr.6270. Epub 2019 Jan 17. Phytother Res. 2019. PMID: 30653773
-
AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study.Lipids Health Dis. 2018 Dec 3;17(1):275. doi: 10.1186/s12944-018-0920-4. Lipids Health Dis. 2018. PMID: 30509277 Free PMC article. Review.
Cited by
-
Fatty liver with metabolic disorder, such as metabolic dysfunction-associated fatty liver disease, indicates high risk for developing diabetes mellitus.J Diabetes Investig. 2022 Jul;13(7):1245-1252. doi: 10.1111/jdi.13772. Epub 2022 Feb 28. J Diabetes Investig. 2022. PMID: 35167194 Free PMC article.
-
AST-to-ALT ratio in the first trimester and the risk of gestational diabetes mellitus.Front Endocrinol (Lausanne). 2022 Sep 29;13:1017448. doi: 10.3389/fendo.2022.1017448. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36246899 Free PMC article.
References
-
- Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–1053. - PubMed
-
- Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non‐insulin‐dependent diabetes mellitus. N Engl J Med 1995; 333: 89–94. - PubMed
-
- Shima T, Uto H, Ueki K, et al. Hepatocellular carcinoma as a leading cause of cancer‐related deaths in Japanese type 2 diabetes mellitus patients. J Gastroenterol 2019; 54: 64–77. - PubMed
-
- Kim CH, Park JY, Lee KU, et al. Fatty liver is an independent risk factor for the development of type 2 diabetes in Korean adults. Diabet Med 2008; 25: 476–481. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical